Today, women diagnosed with gynecologic cancers can be offered hope and a greater promise of survivorship. Over the past 20 years, research investigations conducted in clinics and laboratories across the world have led to progress in how cancers of the ovary, endometrium, cervix, and uterus are prevented, diagnosed, and treated.
Innovative clinical research trials, new and improved chemotherapy regimens, and targeted drug therapies are improving survival rates and outcomes for patients. The prognosis for a patient diagnosed with ovarian cancer has improved from just over one year (14 months) to more than five years (67 months) today. This is progress, but much more needs to happen-and sooner-to save more lives and to transform prevention and detection strategies.
Through investments in priority areas, we can grow our current research and training programs, introduce new clinical, basic, and translational studies, and amplify our scope and impact. In particular, we are seeking private support to:
- Recruit and retain clinicians-scientists through the creation of two endowed research professorships.
- Strengthen our training and teaching programs through the establishment of an endowed medical education professorship.
- Ensure the rigorous training and education of future gynecologic oncology physician specialists and investigators through the endowment of our gynecologic oncology fellowship program.
- Award competitive "idea grants" to investigators who are pursuing novel and promising studies of ovarian cancer, and cancers of the endometrium, cervix, and uterus.
- Strengthen our clinical trial studies through the creation of a Clinical Research Advancement Fund that would provide monies to support study development and regulatory compliance, clinical trial personnel, small equipment, disposable supplies, ancillary services, shared core facility resources, data collection and analysis, and the specialized tests that are integral to conducting clinical trials.
- Advance our educational mission by supporting resident and fellowship training in N-CASE, a state-of-the-art research and education laboratory where medical students, residents, and practicing surgeons gain hands-on experience and training in the most innovative surgical techniques and technologies.
Terri Dillon
Assistant Dean for Development
Northwestern University
Feinberg School of Medicine
420 East Superior Street
Arthur J. Rubloff Building, 9th Floor
Chicago, IL 60611
312.503.4837
E-mail: terri-dillon@northwestern.edu
Complete Gynecologic Oncology Program Vision 
|
|
|
